BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 120 filers reported holding BIOSCRIP INC in Q3 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,549,000 | -2.4% | 2,134,322 | -24.9% | 0.03% | -3.2% |
Q1 2019 | $5,683,000 | -47.0% | 2,841,362 | -5.3% | 0.03% | -50.8% |
Q4 2018 | $10,715,000 | -12.4% | 3,001,459 | -23.9% | 0.06% | +3.3% |
Q3 2018 | $12,233,000 | +3.9% | 3,946,267 | -1.8% | 0.06% | +1.7% |
Q2 2018 | $11,773,000 | +18.7% | 4,017,981 | -0.4% | 0.06% | +17.6% |
Q1 2018 | $9,920,000 | -13.7% | 4,032,415 | +2.0% | 0.05% | -12.1% |
Q4 2017 | $11,501,000 | +10.0% | 3,952,273 | +4.0% | 0.06% | +5.5% |
Q3 2017 | $10,453,000 | -9.8% | 3,801,126 | -11.0% | 0.06% | -12.7% |
Q2 2017 | $11,593,000 | +32.4% | 4,270,069 | -17.1% | 0.06% | +28.6% |
Q1 2017 | $8,757,000 | +58.7% | 5,151,236 | -2.9% | 0.05% | +53.1% |
Q4 2016 | $5,518,000 | -64.0% | 5,305,400 | -0.0% | 0.03% | -66.3% |
Q3 2016 | $15,336,000 | +13.1% | 5,306,619 | -0.2% | 0.10% | +10.5% |
Q2 2016 | $13,559,000 | +77.5% | 5,317,224 | +49.0% | 0.09% | +75.5% |
Q1 2016 | $7,637,000 | +42.8% | 3,568,829 | +16.8% | 0.05% | +40.0% |
Q4 2015 | $5,347,000 | -4.1% | 3,055,476 | +2.5% | 0.04% | -10.3% |
Q3 2015 | $5,574,000 | -41.5% | 2,980,719 | +13.6% | 0.04% | -38.1% |
Q2 2015 | $9,524,000 | – | 2,623,564 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |